KFDA seeks to prevent abuse of propofol

Published: 2010-08-26 06:56:00

Updated: 2010-08-26 06:56:00

The Korean Food and Drug Administration will discuss whether to designate propofol as a narcotic at a special review committee scheduled at the end of this month, officials said.

Despite such abuse potential, propofol is not classified as a narcotic here, making it impossible to impose a legal...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK